← Back to XENE

Xenon Pharmaceuticals Inc. - Common Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Sep 2025Filed 03/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Sep 2024Filed 03/11/2025Jun 2024Filed 03/11/2025Mar 2024Filed 03/11/2025
$0$0$0$0$7.5$0$0$0
−$111−$102−$91−$85−$65−$63−$58−$48
−$1.11−$1.17−$1.15−$1.07−$0.83−$0.81−$0.75−$0.62
10087797979787878

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.